Clene

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.

CEO

Robert Dee Etherington

CEORobert Dee Etherington

Employees

Employees76

Headquarters

Salt Lake City, Utah

HeadquartersSalt Lake City, Utah

Founded

2013

Founded2013

Employees

Employees76

CLNN Key Statistics

Market cap

33.33M

Market cap33.33M

Price-Earnings ratio

-1.36

Price-Earnings ratio-1.36

Dividend yield

—

Dividend yield—

Average volume

42.05K

Average volume42.05K

High today

$3.99

High today$3.99

Low today

$3.50

Low today$3.50

Open price

$3.95

Open price$3.95

Volume

32.95K

Volume32.95K

52 Week high

$6.96

52 Week high$6.96

52 Week low

$2.28

52 Week low$2.28

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CLNN. This list is generated using Robinhood data, and it’s not a recommendation.